Pfizer/BioNTech apply for full FDA approval of updated COVID vaccine

Pfizer/BioNTech apply for full FDA approval of updated COVID vaccine Pfizer Inc and its German partner BioNTech SE said on Friday they filed an application to the U.S Food and Drug Administration (FDA) for a full approval of their Omicron-adapted COVID-19 vaccine. Reuters Reuters

...

The companies are seeking approval of the updated vaccine both as a primary course and a booster dose for individuals 12 years of age and above.

...